uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
A new analytical method based on anti-EPO monolith column and LC-FAIMS-MS/MS for the detection of rHuEPOs in horse plasma and urine samples
Laboratoire des Courses Hippiques (LCH), France.
Laboratoire des Courses Hippiques (LCH), France.
Laboratoire des Courses Hippiques (LCH), France.
Uppsala University, Disciplinary Domain of Science and Technology, Chemistry, Department of Chemistry - BMC, Analytical Chemistry.
Show others and affiliations
2012 (English)In: The Analyst, ISSN 0003-2654, E-ISSN 1364-5528, Vol. 137, no 10, 2445-2453 p.Article in journal (Refereed) Published
Abstract [en]

Recombinant human erythropoietin (rHuEPO) is a 30-34 kDa glycoprotein banned by the racing authorities. For some years this molecule has been detected in race horses in USA and in Europe, and even in racing camels. Although direct methods to differentiate horse endogenous EPO and rHuEPO have been developed either by LC-MS/MS or by isoelectric focusing (IEF) with double-blotting, the short confirmation time of such prohibited hormone in plasma remains a problem for horseracing doping control laboratories. In order to improve the rHuEPOs confirmation process in horse plasma or urine in terms of reliability and delay, a small anti-EPO monolith membrane contained in a disposable column (anti-EPO monolith column) has been successfully used and validated (n = 10). This new sample preparation, combined with LC-FAIMS-MS/MS, has been performed on plasma and urine samples collected from one horse which received an Eprex[registered sign] treatment during six consecutive days and a second one with a single injection of Aranesp[registered sign]. This inventive technology allowed the possibility to confirm the presence of rHuEPO within one day with a limit of detection validated for both urine and plasma at 250 pg mL-1 by means of a disposable, ready to use immunoaffinity column. The lower limit of detection (LLOD) obtained for each matrix was 100 pg mL-1. These results provide an important improvement for rHuEPO doping control in horseracing especially the possibility to confirm these banned molecules in both matrices, urine and plasma, with a confidence of two specific target peptides.

Place, publisher, year, edition, pages
2012. Vol. 137, no 10, 2445-2453 p.
National Category
Chemical Sciences
URN: urn:nbn:se:uu:diva-173871DOI: 10.1039/C2AN15662HISI: 000303126000027OAI: oai:DiVA.org:uu-173871DiVA: diva2:525445
Available from: 2012-05-08 Created: 2012-05-08 Last updated: 2012-05-28Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Lönnberg, Maria
By organisation
Analytical Chemistry
In the same journal
The Analyst
Chemical Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 444 hits
ReferencesLink to record
Permanent link

Direct link